Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nanosonics Limited ( (AU:NAN) ) has shared an update.
Nanosonics Limited has continued executing its on-market share buy-back program, reporting that it repurchased 142,097 ordinary fully paid shares in the latest trading day, bringing the total number of shares bought back so far to 3,805,734. The ongoing daily buy-back notifications signal that the company is actively returning capital to shareholders and potentially seeking to optimise its capital structure, which may support earnings per share and indicate management’s confidence in the business, while modestly reducing the free float in the market.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$4.50 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is a medical technology company listed on the ASX under the code NAN, specialising in infection prevention solutions for healthcare, with its shares traded as ordinary fully paid securities. The company targets hospitals and clinical settings, where stringent disinfection standards and reliable device reprocessing are critical to patient safety and regulatory compliance.
Average Trading Volume: 673,371
Technical Sentiment Signal: Sell
Current Market Cap: A$1.14B
For detailed information about NAN stock, go to TipRanks’ Stock Analysis page.